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Larva migrans: A CASE REPORT AND REVIEW
Paulo Eduardo Neves Ferreira VELHO(1), Andreia Vasconcellos FARIA(1), Maria Letícia CINTRA(2),
Elemir Macedo de SOUZA(1) & Aparecida Machado de MORAES(1)
SUMMARY
A case of massive Ancylostoma sp. larval infestation is presented in a patient who had received systemic corticosteroid therapy.
What attracts attention in this case is the exuberance and rarity of clinical manifestation. Based on the pertinent literature, we discuss
the mechanisms of parasital infection, the natural history of the disease and its treatment.
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INTRODUCTION
Creeping eruption, as it is also called, was described by Lee in 1874.
Subsequently, the term larva migrans was linked to the Ancylostoma sp.
larva by White and Dove in 19289,10. It is one of the most frequent
cutaneous infestations in warm countries (Latin America, the Caribbean,
Africa, Southeast Asia and South-Western United States)4. It is also the
most common travel-associated dermatoses in tourists who travel to
tropical areas2.
With a predominantly clinical diagnosis in the most prevalent areas,
it is usually under-diagnosed in temperate countries. This fact leads to a
delay in starting treatment and, not infrequently, to the exacerbation of
the clinical manifestation, often aided by the mistaken prescription of
corticosteroid.
CASE REPORT
A 44-year-old Caucasian man, truck driver, came to the State
University of Campinas (Unicamp), Dermatology Clinic stating that three
months before he had been victim of assault and battery, which left him
unconscious on the ground for several hours. He had been hospitalized
in coma and given intravenous therapy with corticoid for cerebral edema.
Upon regaining consciousness days later, he noted erythematous,
edematous and intensely pruritic lesions on the left frontal region and
on the left parietotemporal, preauricular, orbicular and malar ones (Figs.
l and 2). At the same time, similar lesions appeared in the deltoidal region
(Fig. 3) and arm, and other sparse lesions on the abdomen and upper
thigh, all on the left side.
He also reported having been subsequently seen by several doctors
who prescribed corticoid of diverse strengths.
When examined, he had confluent, eczematoid, edemato-infiltrative,
cerebriform and peau d’orange-looking lesions on the cephalic segment
in the aforementioned regions. There were small papules of up to 5 mm,
palpable further beyond. On the left arm and deltoidal region, there were
erythematous infiltrated papules of 5 to 10 mm, and other erythematous
serpiginous ones. There were also isolated lesions on the abdomen and
thigh. Most of these were follicular.
The skin biopsy performed on the fronto-parietal and deltoidal
regions showed dermoepidermitis, both subacute and chronic, superficial
and deep, with multiple foci of eosinophilic folliculites (Fig. 5). Focally,
in a superficial vein, a circular structure could be seen, with an external
lining of keratin, suggesting Ancylostoma sp. larva (Fig. 6).
The patient was treated with albendazole, 400 mg per day for three
days. Due to the severity of the lesions, a second cycle was prescribed
after 21 days. At the end of the treatment, there was a complete regression
of the manifestations, with recovery of hair growth of the alopecic areas
associated with the lesions (Fig. 4). After 24 months, the patient stated
that he had not had any more cutaneous lesions.
REVIEW OF THE LITERATURE
The causal agents of larva migrans are the A. braziliense and the A.
caninum, whose eggs are found in dog and cat faeces. Some authors
also consider the Uncinaria stenocephala, the Gnathostoma spinigerum
and the Bunostomun phlebotomum as causal agents9. Others, however,
indicate subtle differences in the appearance of the lesions, which leads
them to characterize them as distinct dermatoses4,12. Man is an accidental
host to these hookworms. Cats and dogs are definitive hosts4.
The larvae in the soil, in their third stage, penetrate the organism
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Fig. 1 - Larva migrans - left side cephalic segment with confluent, edemato-infiltrates, and
cerebriform lesions.
Fig. 4 - Patient after l month of treatment, without lesions, and with complete recovery of
hair growth.
Fig. 3 - Larva migrans - left deltoidal region with erythematous and infiltrate papules, and
other erythemato-serpiginous.
Fig. 2 - Larva migrans - close-up of the previous picture where one observes eczematoid
aspects and peau d’orange of the fronto-temporal region.
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through the skin, reaching the veins in the dermis of these animals. They
migrate to the lungs and then the trachea, being degluted. The adult
worms reproduce in the intestine and the eggs are eliminated in the faeces4.
The larvae are wrapped in a protective pellicle, permeable only by
gases. Attracted by the high concentration of carbon dioxide in the skin,
they lose their carapaces, releasing proteases. These enzymes will enable
them to migrate through the epidermis. Some authors consider the A.
braziliense incapable of reaching the dermis since it does not have specific
collagenases9.
HOLTEZ et al. demonstrated in 1992 that the larval forms of this
nemathelmintes, as well as the A. caninum, produce two enzymes
responsible for the tissue invasion: the proteases and the hialuronidases6.
The latter have similar characteristics to those found in mammal
spermatozoids.
The hialuronidases of these invertebrates are said to facilitate the
migration through the skin and detach the cells of the basal membrane
of the epidermis, strongly joined by the hialuronic acid. This enzyme in
the A. braziliense in vitro is more active than the A. caninum, and both
of them are more active than that of other ancylostomas. Whence the
ease with which these two species lead to cutaneous infestation, unlike
other Ancylostoma sp.6.
Eosinophil-derived major basic protein and eosinophil cationic
protein are the main means by which the host overcomes the energy
reserves of the larva, resulting in its incapacitation and elimination9.
The incubation period is usually short and vaguely established, one
or two weeks being the estimate. Experimental studies show that the
larvae penetrate the pillous follicules and the orifices of the sebaceous
glands. They begin migration four days after penetration and are more
active at night2,4,5,12 .
The main affected areas are the dorsum and sole of the feet (uni and
bilateral), buttocks, pelvic waist, legs and shoulders. More than one lesion
is compatible with more than one entry point4.
The main signs and symptoms are linear and/or serpiginous lesions
(which progress from 2 - 3 mm to 2 - 3 cm per day) and the pruritus.
This is intensified after some days by the inflammatory reaction of the
host and may even interfere with sleep. Pain may occur in papulovesicular
lesions2,4.
Infestation is usually self-limited, as the larva resists for anything
between two days and a few weeks, although it may occasionally persist
for more than a year3,4.
Fig. 5 - Larva migrans – a rich in eosinophils, chronic inflammatory process, with epidermic
hyperplasia, fibrosis, hypervascularization, and edema in the dermis. In the center of the
fragment, presence of the follicular eosinophilic abscess. (HE, original magnification x100).
Fig. 6 - Larva migrans – small vein in the papillar dermis containing traces of larva. Exuberant
peri-vascular inflammatory exudates rich in eosinophils (HE, original magnification x400).
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Infestation with A. caninum usually spreads more, with systemic
manifestations, folliculitis and migration to the muscles of the region9.
The diagnosis is essentially clinical and the histological features
usually contribute very little to it. Wilson evaluated 300 biopsies of larva
migrans lesions in 1951 and found larval structures in only eight, as
reported by MILLER et al., 19919. The latter authors describe the finding
of a A. caninum structure, and eosinophilic folliculitis in a patient with
a clinical diagnosis and histological confirmation. They mention only
one previous description of folliculitis associated clinically with larva
migrans. CAUMES et al.,1995, clinically associate follicular lesions
with serpiginous dermatitis in two out of 67 patients with this diagnosis2.
The main differential diagnosis should be made with the larva
currens, caused by Strongyloides stercoralis, whose lesions, linear and
urticated, grow on average 10 cm per day12. There may also be similarities
with the chronic migratory erythema of Lyme’s disease4.
The main therapeutic schemes are thiabendazole, 15% cream, applied
2 to 3 times on the affected areas for 5 days. Symptoms should cease
within 48 hours. Albendazole can be administered in a single dose of
400 mg or in the same daily dose for 3 to 5 days4,7,8,9.
Ivermectin may be administered in a single dose of 12 mg with
excellent results, according to CAUMES & GENTILINI, 19933.
Thiabendazole, taken orally, is not recommended because it is poorly
effective in comparison with the other therapeutic options, especially in
a single dose1. One reason may be that the protective pellicle of the third
stage of the larva is impermeable to thiabendazole9. In addition, its side
effects such as nauseas, vomiting, vertigo and chronic headache also
limit its use3.
JONES, 1994, described the recrudescence of lesions after 3 days of
albendazole, although he still considers it the best therapeutic option.
This may have happened, according to him, because of the variable
absorption of the drug, or because the infestation was massive. He
recommends a later evaluation of patients with this condition7.
DISCUSSION
We have related a case of larva migrans with an unusual
manifestation.
With regard to symptoms, the patient mentioned pain, which occurs
in only 10% of cases4.  In the literature, this symptom is more associated
with vesiculous lesions, and in this patient an eczematous aspect in the
cephalic segment was observed.
The histological finding of rich eosinophilic infiltrate, added to the
information about anamnesis, led to the diagnosis. This was confirmed
by finding the larval structure after exhaustive search. Besides identifying
the keratin structure inside the blood vessel, which shows larva invasion,
the anatomopathological exam showed various areas of folliculites with
rich infiltration of eosinophils, as in the case described by MILLER et
al., 19919.
Clinical and histological finding of folliculitis and the linking of
larval structure to histology, as in this case, are described in the literature
as rare and more usually associated with A. caninum.
Repetition of treatment with albendazole is supported by the case of
recrudescence already cited7, and by the fact that this was a case of
massive infestation. Therapeutic success was confirmed by reevaluation
after a prolonged period of treatment.
It is thought that prolonged contact of the broad affected areas with
the sun may have allowed entry of multiple larvae. The presence of many
spots of folliculites may be due to larval penetration through orifices of
the pillo-sebaceous apparatus, as suggested by experimental studies
already mentioned and observed by GUIMARÃES et al., 19995.
The clinical exuberance may have been aided by transitory
immunodeficiency caused by corticosteroid. This diminishes the
cutaneous inflammatory response in many ways, such as the inhibition
of phospholipase A2, of the action of cytokines, of the expression of
ELAM-1 and ICAM-1, and of the liberation of histamine. In this way, it
becomes efficient in suppression of the eosinophilic activity and may
have increased susceptibility to this infestation11.
RESUMO
Larva migrans: relato de caso e revisão
É apresentado um caso de infestação maciça por Ancylostoma sp.
em paciente que recebeu terapia sistêmica com corticosteroide. O que
chama a atenção neste caso é a exuberância e a raridade da manifestação
clínica. Com base na literatura pertinente, discutimos os mecanismos da
infecção parasitária, a história natural da doença e seu tratamento.
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